Close
CDMO Safety Testing 2026
Novotech

Sharp Expands Commercial Packaging Capabilities to UK Facility

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity

Informa Markets has announced that CPHI Americas will relocate...

Aragen Achieves Daretabart Commercial-scale GMP Production

Aragen, a global leader in Contract Research, Development, and...

Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe

Nestlé Health Science and IdB Holding have officially announced...
- Advertisement -

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has invested £1 million in a commercial expansion project at its site in Rhymney, UK.

Since the Rhymney facility opened in late-2019 as a clinical packaging centre of excellence, the company has received a number of enquiries for commercial primary and secondary packaging services.

After making the investment and receiving a commercial license in January of this year, Sharp can now meet demand for commercial packaging of a number of drug formats, including cold and thermoform blisters, bottles, capsules and medical device kitting.

The capacity expansion included new primary and secondary packaging rooms as well as installation of blistering equipment and automated cartoners. The new integrated lines feature inline conveyor systems and automatic blister feeding to increase capacity and offer faster packaging lead times.

Sharp is planning to introduce new serialisation, aggregation and authentication equipment with further investment to support broader service delivery and future growth within the company for new and existing customers.

Commercial blister production at the site will begin in June 2020.

Sharp has invested over $70 million on its global facilities over recent years including:

$21m on expanding capacity and capabilities at its Allentown and Conshohocken, PA facilities
$11m on its new Clinical Services Centre of Excellence in Wales
$11m on enhancing its injectable and cold chain capabilities in the US, Belgium and the Netherlands
$23m on its refitted state-of-the-art clinical facility in Bethlehem, PA.
$13m on the redevelopment of Sharp Heerenveen, The Netherlands

About Sharp

Sharp, part of UDG healthcare, is a global leader in contract packaging and clinical services. Operating from eight state-of-the-art facilities across the US and Europe, Sharp has built an international reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. We are also a world leader in ’Track and Trace’ and serialization services, with over eleven years’ experience in implementing serialized solutions for our pharma clients.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity

Informa Markets has announced that CPHI Americas will relocate...

Aragen Achieves Daretabart Commercial-scale GMP Production

Aragen, a global leader in Contract Research, Development, and...

Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe

Nestlé Health Science and IdB Holding have officially announced...

CordenPharma Seals AmbioPharm Deal to Expand Global Network

CordenPharma, a global contract development and manufacturing organization specializing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »